Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Base de datos
Tipo del documento
Asunto de la revista
País de afiliación
Intervalo de año de publicación
1.
Dev Comp Immunol ; 122: 104077, 2021 09.
Artículo en Inglés | MEDLINE | ID: mdl-33905781

RESUMEN

As an invertebrate, the compound ascidian Botryllus schlosseri faces nonself only with innate immunity. In this species, we already identified the key components of the lectin and alternative complement activation pathways. In the present work, by mining the transcriptome, we identified a single transcript codifying for a protein, member of the C1q-domain-containing protein family, with a signal peptide followed by two globular C1q (gC1q) domains. It shares a similar domain organisation with C1q/TNF-related proteins 4, the only vertebrate protein family with two gC1q domains. Our gC1q domain-containing protein, called BsC1qDC, is actively transcribed by immunocytes. The transcription is modulated during the Botryllus blastogenetic cycle and is upregulated following the injection of Bacillus clausii cells in the circulation. Furthermore, the injection of bsc1qdc iRNA in the vasculature results in decreased transcription of the gene and a significant impairment of phagocytosis and degranulation, suggesting the involvement of this molecule in immune responses.


Asunto(s)
Complemento C1q/inmunología , Inmunidad Innata/inmunología , Opsonización/inmunología , Urocordados/inmunología , Secuencia de Aminoácidos , Animales , Bacillus clausii/inmunología , Degranulación de la Célula/inmunología , Complemento C1q/genética , Hemocitos/metabolismo , Fagocitosis/inmunología , Dominios Proteicos , Interferencia de ARN , ARN Interferente Pequeño/genética , Transcriptoma/genética
2.
Expert Rev Gastroenterol Hepatol ; 10(8): 943-8, 2016 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-27291780

RESUMEN

INTRODUCTION: The intestinal barrier is a complex system responsible for the host health. Many gastrointestinal and extra-intestinal diseases are associated to gut barrier disruption. An increasing interest on nutritional supplements and functional foods focused on the hypothesis that specific prebiotics and probiotics may modulate and interact with gut barrier, re-establishing gut homeostasis. AREAS COVERED: The application of preparations containing B. clausii in the treatment or prevention of gut phisiology impairment has been largely supported in the last years and has driven its clinical applications. This review focuses on B. clausii clinical applications and speculates on the possible interactions among B. clausii, gut barrier and immune system and on the consequences of this interplay in modulating human health. Expert commentary: Its favorable effects have been linked to several properties, such as antimicrobial and immunomodulatory activity, regulation of cell growth and differentiation, cell-cell signaling, cell adhesion, signal transcription and transduction, production of vitamins and gut protection from genotoxic agents. In this scenario, future studies will need to better clarify its mechanisms of action and focus on the possible role of B. clausii in modulating gut immune system.


Asunto(s)
Bacillus clausii/fisiología , Enfermedades Gastrointestinales/terapia , Microbioma Gastrointestinal , Intestinos/microbiología , Animales , Bacillus clausii/inmunología , Disbiosis , Enfermedades Gastrointestinales/inmunología , Enfermedades Gastrointestinales/microbiología , Enfermedades Gastrointestinales/fisiopatología , Homeostasis , Interacciones Huésped-Patógeno , Humanos , Inmunidad Mucosa , Mucosa Intestinal/inmunología , Mucosa Intestinal/microbiología , Intestinos/inmunología , Intestinos/fisiopatología , Probióticos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA